Company intelligence / Profile preview

Omnicell

Mountain View, California, United Statesomnicell.co.uk ↗

Ownership: Public · OMCL
Employees: ~3500
Development stage: Commercial

Overview

Omnicell provides commercialized hardware and software platforms for automating and optimizing pharmacy operations in hospitals, clinics, and retail pharmacies. Their systems are widely adopted globally with proven results in improving efficiency, reducing costs/errors, supporting compliance, and enhancing patient safety. The company does not conduct clinical trials as it does not develop therapeutics.

Therapeutic areas: Other
Modalities: DeviceSoftwareRobotics
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

GollmannTrackTraceRXLSPedia

Financials

Market cap: $1.5B
Total revenue: $312.2M
Enterprise value: $1.4B

Beyond the preview

Go deeper on Omnicell.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Omnicell.

Explore the full profile